Drug profile
The FDA adverse-event record for Firocoxib 227 Mg Chewable
999 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Firocoxib 227 Mg Chewable. See the species affected, top reactions, and outcomes below.
- 999
- adverse-event reports
- 16.6%
- death-coded share
- Dog
- most-reported species
- 294
- Vomiting - top reaction
Active Ingredients
Administration Routes
Species Affected
Most Affected Breeds
Most Reported Reactions
Outcome Breakdown
Firocoxib 227 Mg Chewable Adverse Event Insights
999 reports name Firocoxib 227 Mg Chewable; 166 recorded a death outcome (16.6% of reported events, not a population-level mortality rate). Active ingredient: Firocoxib 227 Mg Chewable. Administration routes: Oral, Unknown, Topical.
By species: Dog (832 reports), Unknown (138 reports), Horse (17 reports). By breed: Retriever - Labrador (174), Unknown (148), Crossbred Canine/dog (81).
Leading clinical signs: Vomiting (294), Other abnormal test result NOS (244), Lethargy (see also Central nervous system depression in 'Neurological') (146), Elevated blood urea nitrogen (BUN) (145). Outcome, 862 coded reports: Outcome Unknown leads at 49.1%.
Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.